Robert Langer

Robert Langer
cmichel67 · CC BY-SA 4.0 · source
Name	Robert Langer
Birth date	1948
Birth place	Albany, New York
Nationality	United States
Fields	Chemical engineering, Biotechnology
Institutions	Massachusetts Institute of Technology, MIT
Alma mater	Cornell University, University of Cambridge, Massachusetts Institute of Technology School of Engineering

Robert Langer Robert Langer is an American chemical engineer and entrepreneur noted for contributions to drug delivery, biomaterials, and biomedical engineering. He holds a longstanding faculty position at Massachusetts Institute of Technology and has cofounded numerous biotechnology companies, influencing translational research and industrial partnerships across pharmaceutical industry and medical device sectors. His work intersects with materials science, polymer chemistry, and translational medicine, contributing to therapies, diagnostics, and regulatory science.

Early life and education

Langer was born in Albany, New York and grew up in a family with connections to Brooklyn and New York City. He attended Cornell University where he studied chemical engineering under mentors linked to the department and pursued graduate studies at the Massachusetts Institute of Technology School of Engineering and as a visiting researcher at the University of Cambridge. His doctoral and postdoctoral advisors included leading figures associated with biomaterials research and polymer science in the United States and the United Kingdom. Early influences included researchers from Harvard University, Stanford University, California Institute of Technology, and industrial laboratories such as Merck & Co., Pfizer, and Eli Lilly and Company where contemporaries were active in translational research.

Academic career and research

Langer joined the faculty of Massachusetts Institute of Technology and rapidly established a multidisciplinary laboratory that collaborated with groups at Harvard Medical School, Brigham and Women's Hospital, Children's Hospital Boston, and Dana–Farber Cancer Institute. His laboratory advanced controlled release systems informed by work in polymer chemistry, macromolecular engineering, and tissue engineering. Key research topics connected to his group include sustained-release formulations for agents developed by GlaxoSmithKline, AstraZeneca, and Novartis; encapsulation technologies paralleling concepts from Johnson & Johnson and Boston Scientific; and nucleic acid delivery strategies relevant to Pfizer–BioNTech and Moderna. Collaborations and citations involved investigators at National Institutes of Health, National Science Foundation, Howard Hughes Medical Institute, and international centers such as Max Planck Society, Karolinska Institutet, University of Tokyo, and Imperial College London.

His contributions influenced subfields tied to oncology therapeutics used in trials overseen by Food and Drug Administration panels and ethics committees at Institutional Review Boards. Methodologies from his lab drew on techniques from electron microscopy groups at Lawrence Berkeley National Laboratory and bioinformatics approaches developed at Sanger Institute and European Bioinformatics Institute. Langer's students and postdocs have moved to faculty positions at Yale University, University of California, Berkeley, University of Pennsylvania, Columbia University, University of Michigan, California Institute of Technology, Duke University, Johns Hopkins University, University of Washington, University of Texas Southwestern Medical Center, and international institutions including University of Oxford and University of Cambridge.

Entrepreneurship and commercialization

Langer cofounded numerous companies that translated laboratory inventions into commercial products, partnering with venture capital firms such as Sequoia Capital, Andreessen Horowitz, and New Enterprise Associates. Spinouts and collaborations included ventures aligned with Alnylam Pharmaceuticals, Editas Medicine, Beam Therapeutics, Intellia Therapeutics, CRISPR Therapeutics, Genentech, Amgen, and medical startups working on implantable devices similar to those from Medtronic and Stryker Corporation. Licensing agreements and partnerships engaged with Novartis Institutes for BioMedical Research, Roche, Takeda Pharmaceutical Company, and Bayer. Technology transfer offices at MIT Technology Licensing Office facilitated commercialization, while accelerators like MassChallenge, Y Combinator, and Techstars provided ecosystem support. His entrepreneurial network connected to investors including SoftBank Vision Fund, Khosla Ventures, and Flagship Pioneering.

Awards and honors

Langer has received major recognitions from institutions and societies including awards from the National Academy of Engineering, National Academy of Sciences, Institute of Medicine, American Association for the Advancement of Science, and American Chemical Society. Prestigious prizes associated with his career include honors from The Queen, medals parallel to those awarded by Royal Society, distinctions akin to the National Medal of Science and National Medal of Technology and Innovation, and international awards involving the Lasker Foundation, Wolf Foundation, Gairdner Foundation, Breakthrough Prize and humanitarian recognitions from organizations like UNESCO and World Economic Forum. He has held named lectureships at Rockefeller University, Cold Spring Harbor Laboratory, Woods Hole Oceanographic Institution, Salk Institute, and delivered keynote addresses at conferences organized by American Institute of Chemical Engineers, Materials Research Society, Society for Biomaterials, and Biomedical Engineering Society.

Personal life and legacy

Langer's personal network includes collaborations with scientists and entrepreneurs from Harvard University, Stanford University School of Medicine, MIT Media Lab, and policy interactions with United States Congress committees on science and technology. His mentorship produced leaders at startups, academic departments, and institutions such as MIT Lincoln Laboratory and National Institutes of Health Clinical Center. His legacy is reflected in textbooks and curricula at Princeton University, Brown University, University of California, San Diego, and Rice University, and in continuing impact on translational pipelines at entities like Mass General Brigham, Beth Israel Deaconess Medical Center, and Kaiser Permanente. He has influenced philanthropic initiatives at Bill & Melinda Gates Foundation, Howard Hughes Medical Institute, and Koch Foundation tied to biomedical innovation.

Category:American chemical engineers Category:Massachusetts Institute of Technology faculty